GSK2646264
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK2646264, covering 2019-06-21 to 2019-07-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects [Phase 1]